Early research (Phase 1)Study completedNCT02827968
What this trial is testing
Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Who this might be right for
Solid Tumors
3D Medicines (Sichuan) Co., Ltd. 28